CordenPharma Colorado Partners with BioMed Realty on Peptide Development Lab Expansion
Full-building, 15-year lease for 64,000 square feet enables CDMO CordenPharma Colorado to power next-generation peptide development in Boulder, Colorado.
Pharma
Symbiosis Appoints Joanne Anderson as Chief Commercial Officer
Symbiosis Pharmaceutical Services has appointed experienced commercial leader Joanne Anderson as Chief Commercial Officer to drive global growth following recent capacity investments and expansion plans.
Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy
Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.
Lonza Divests Capsules & Health Ingredients Business for $3 Billion
Lonza signs agreement to divest its Capsules & Health Ingredients (CHI) business to Lone Star Funds, for an enterprise value of $3 billion (CHF 2.3 billion).
Forma Life Sciences Launches US Based CDMO
Forma Life Sciences launches as US-based contract development and manufacturing organization (CDMO) for oral solid dosage development and commercial manufacturing in Irvine, California.
Small Molecules: Choosing a Strategic, Scalable, and De-Risked Development Path
Early CMC decisions determine success. Learn how structured planning and enabling technologies accelerate small-molecule programs to the clinic.
Leading CROs and CDMOs Turn to Mass Photometry for Rapid Protein, mRNA and Viral Vector Analytics
As CROs and CDMOs expand their role in biopharma development and manufacturing, fast, accurate bioanalytic technologies remain critical to biotherapeutic affordability.
Asahi Kasei Acquires Aicuris for €780 Million
Asahi Kasei will acquire all shares in the German biopharmaceutical company Aicuris Anti-infective Cures for approximately €780 million.
AbbVie to Invest $380 Million in Chicago to Further Expand US API Manufacturing
Investment marks continued progress against AbbVie's $100 billion commitment to US R&D and capital investments, including manufacturing, over the next decade.
DFE Pharma Launches Continuous Manufacturing Platform for Formulation Development
DFE Pharma announces the launch of its continuous manufacturing (CM) platform. It is designed to support pharmaceutical companies in the development, optimization, and lifecycle management of CM processes.
Axplora Expands Le Mans Lyophilization Operations, Appoints New Head of Site
Axplora announced a multi-million-euro investment to expand lyophilization capabilities at its Le Mans site and appointed François Houbart as Head of Site.
Alkermes Completes $2.1 Billion Acquisition of Avadel Pharmaceuticals
Alkermes has finalized its acquisition of Avadel Pharmaceuticals, bolstering its presence in the sleep medicine market.
Sanofi Appoints Belén Garijo as CEO
Belén Garijo to become Chief Executive Officer of Sanofi.
AsymBio Launches End-to-End Tech Platforms for Biopharma Lifecycle
AsymBio, a subsidiary of Asymchem Group, has established integrated technology platforms including cell line development, upstream/downstream processing, conjugation toolbox, and analytics.
Fujifilm Biotechnologies Unveils Biomanufacturing & Process Development UK Expansion
Fujifilm Biotechnologies expanded manufacturing and process development presence in the North East of England to support vital biomanufacturing of innovative medicines and vaccines in the United Kingdom.
Rentschler Biopharma Appoints Veit Bergendahl as COO
Veit Bergendahl will assume operational responsibility for process development, clinical and commercial cGMP manufacturing, engineering and technology as well as automation in production from April 1, 2026.
Sanofi Completes Acquisition of Dynavax for $2.2 Billion
Sanofi has completed its acquisition of Dynavax, adding its adult vaccines and pipeline candidates to strengthen Sanofi’s presence in adult immunization.
WuXi Biologics Boosts Complex Biologics Pipeline
WuXi Biologics partners with Sinorda on bispecific antibodies for autoimmune diseases and HanchorBio on fusion proteins for oncology and immunology.
Sharp Services Invests Over €20 Million to Expand Injectables Packaging Capacity
Sharp Services has invested over €20 million to expand injectables packaging capacity at its facilities in Hamont-Achel, Belgium, and Heerenveen, Netherlands, with significant cold chain enhancements.
Siegfried to Acquire Small Molecules Drug Substance Capacity in the US
Siegfried signed binding agreements to acquire three drug substance sites in the US and Australia.
API Manufacturing
Accelerating API Excellence: Innovation, Quality, and Compliance in Pharmaceutical Manufacturing
Tjoapack Boosts Bottle Packaging Capabilities at Netherlands Facility
Tjoapack is expanding its oral solid dose (OSD) bottle packaging capabilities at its Etten-Leur, Netherlands, facility, enhancing flexibility, efficiency, and GMP-compliant packaging options to meet growing demand.
Johnson & Johnson Delivers on Multibillion-Dollar US Manufacturing and Innovation Investments
Company announces two new additional manufacturing facilities to be built in North Carolina and Pennsylvania; continues to deliver on $55 billion US investment.
AbbVie to Acquire Arizona Manufacturing Facility
AbbVie will acquire West Pharmaceutical Services’ Tempe, Arizona, manufacturing facility for over $175 million to expand US drug delivery device capacity, with closing expected mid-2026.
Sharp Sterile Manufacturing Increases Capacity with $28 Million Investment
Sharp Sterile Manufacturing announced a $28 million expansion of its Lee, Massachusetts site to boost pharmaceutical production capacity and create high-skilled life sciences jobs.
From Isolation to Insight: Fluorescence Imaging of EVs in Liquid Biopsy Workflows
This infographic hopes to provide scientists with a comprehensive overview of fluorescence imaging strategies for extracellular vesicle research.
Adapting, Partnering, and Innovating: Insights from CPhI Frankfurt
How CDMOs are navigating uncertainty, forging partnerships, and embracing flexibility.
Symbiosis Begins Commercial Production at FDA-inspected Manufacturing Facility
Symbiosis Pharmaceutical Services has begun commercial production at its new FDA-inspected and MHRA-licensed facility in Stirling, UK.
AstraZeneca to Invest $2 Billion in US Biologics Facility
Fourth major US manufacturing investment announced this year, advancing AstraZeneca’s historic $50 billion commitment to medicines manufacturing and R&D.
Halozyme Acquires Drug Delivery Company Elektrofi
Halozyme has acquired Elektrofi to expand its drug delivery portfolio, with royalty revenues expected to start by 2030 as partnered products advance to clinical development.
Thermo Fisher Opens Advanced Therapies Collaboration Center in Philadelphia
New state-of-the-art facility in Philadelphia provides integrated lab and collaboration space along with tailored guidance to help move advanced therapies from early research to clinical readiness.
AGC Biologics Partners with Rarity PBC to Commercialize Breakthrough Gene Therapy
AGC Biologics has partnered with Rarity PBC to provide development and GMP manufacturing of a gene therapy aimed at treating a rare, life-threatening immune disorder.
Johnson & Johnson Acquires Halda Therapeutics for $3.05 Billion
Johnson & Johnson is acquiring clinical-stage biotech Halda Therapeutics for $3.05 billion to enhance its oncology pipeline.
Novartis Launches $23 Billion North Carolina Manufacturing Hub
Novartis plans to establish a flagship manufacturing hub in North Carolina by 2027-2028 as part of a $23 billion investment in US infrastructure.
Navigating the Complexities of Early Drug Development
This infographic provides industry professionals and senior scientists with insights into detailed methodologies for addressing stability challenges in protein therapeutics.
Saltigo GmbH
Brenntag SE
PureTech Systems
VCI Verband Chem.- Ind. e.V
Oxford Instruments
IMCD Group B.V.
LISA Life Science Austria
Managm. Consult. Chemicals
Johnson & Johnson
Abzena
Hovione
Camelot Management Consultants AG
Porsche Consulting
ISPE D/A/CH e.V.
Pfizer, Inc.
Forma Life Sciences
AstraZeneca
Roquette
ACG
AGC Biologics
GETEC Group
Harke Group GmbH
AmbioPharm, Inc.
AbbVie Inc.
F. Hoffmann-La Roche Ltd
Fujifilm
UBM Live
Refeyn Ltd.
Scienceindustries - Wirtschaftsverband Chemie Pharma Life Sciences
CPA Chemical Pharmac. Ass.
Codexis
WeylChem International GmbH
Curia
Datamonitor Group
Siegfried
Bayer AG - Pharmaceuticals Communications & Health Policy
Symeres
Gilead Sciences, Inc.
BASF SE
A.T. Kearney GmbH
Sharp Services
Avantor
CMS Advisors GmbH & Co. KG
Packaging Coordinators, Inc.
Rentschler Biopharma SE
Alkermes
EvaluatePharma
Ontario Int. Marketing Ct.
LGC Group
Universität Hohenheim - Institut für Lebensmitteltechnik